Drug pricing
ABPI hits back at Prime Minister’s criticism of high drug prices
October 15, 2015Sales and Marketing ABPI, Drug pricing, Duchenne Muscular Dystrophy, NICE, Translarna, ataluren, david cameron, prime minister, rare disease
The ABPI has responded to comments made by UK Prime Minister David Cameron during yesterday’s Prime Minster’s Questions, in which …
Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters
October 14, 2015Drug pricing, Hilary Clinton, US, pricing reform
Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …
Alexion to challenge Canadian price of Soliris in court
September 28, 2015Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris
Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …
Price tags on medicine packs a “headline grabbing gimmick”
August 7, 2015Manufacturing and Production, Medical Communications Drug pricing, Jeremy Hunt, NHS, adherence, compliance
Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …
Pfizer and Flynn rapped for overcharging on anti-epilepsy drug
August 6, 2015Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing
Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …
Novo Nordisk pulls Tresiba in Germany after pricing row
July 6, 2015Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access
Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
Chinese government to lift drug price controls
May 5, 2015Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government
The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
The Pharmafocus debate: Is the price of new hepatitis C treatments fair?
April 27, 2015Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi
YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …
Researchers question ‘bias’ NICE on statins
June 11, 2014Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins
Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …
NHS documentary counts cost
April 25, 2014Medical Communications, Sales and Marketing Channel 4, Drug pricing, NHS, PPRS, vba
The funding issues facing the NHS are to be explored in a new documentary series on Channel 4. Set to …
New UK drug pricing plans ‘delayed’
October 7, 2013Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP
ABPI ‘fears for future of UK research’ ahead of pricing talks
June 7, 2012Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP
The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …
Boehringer-Lilly won’t launch Trajenta in Germany
September 5, 2011Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts
Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …
Philippines pricing controls: Pfizer ‘considered taking drugs off the market’
September 2, 2011Sales and Marketing Drug pricing, Philippines, price cuts
Pfizer considered withdrawing some of its products from the Philippines rather than face planned pricing controls, according to a US …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
